{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:47:01Z","timestamp":1783648021452,"version":"3.55.0"},"reference-count":159,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.yexcr.2024.114279","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:26:37Z","timestamp":1728501997000},"page":"114279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The emerging role of miRNAs in pituitary adenomas: From molecular signatures to diagnostic potential"],"prefix":"10.1016","volume":"442","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-7096","authenticated-orcid":false,"given":"Ahmed S.","family":"Doghish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gharieb S.","family":"El-Sayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai A.","family":"Abd-Elmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al-Aliaa M.","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar Mohammed","family":"El Tabaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwat Abdelhady","family":"Mangoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohada M.","family":"AL-Noshokaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Bakr","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walaa A.","family":"El-Dakroury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud A.","family":"Elrebehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Ahmed","family":"Abdel-Reheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-5212","authenticated-orcid":false,"given":"Mohammed S.","family":"Elballal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7876-3425","authenticated-orcid":false,"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The epidemiology of pituitary adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol. Metabol. Clin"},{"issue":"16","key":"10.1016\/j.yexcr.2024.114279_bib3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1001\/jama.2023.5444","article-title":"Diagnosis and management of pituitary adenomas: a review","volume":"329","author":"Tritos","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib4","first-page":"319","article-title":"Pituitary adenomas: an overview","volume":"88","author":"Lake","year":"2013","journal-title":"Am. Fam. Physician"},{"issue":"19","key":"10.1016\/j.yexcr.2024.114279_bib5","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.3390\/ijms21197287","article-title":"MiRNAs as noninvasive biomarkers and therapeutic agents of pituitary adenomas","volume":"21","author":"Beylerli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.yexcr.2024.114279_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.yexcr.2024.114279_bib8","doi-asserted-by":"crossref","first-page":"R375","DOI":"10.1530\/ERC-20-0136","article-title":"The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs)","volume":"27","author":"Yavropoulou","year":"2020","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community\u2010based, cross\u2010sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib10","first-page":"613","article-title":"The prevalence of pituitary adenomas: a systematic review, Cancer","volume":"101","author":"Ezzat","year":"2004","journal-title":"Interdisciplinary International Journal of the American Cancer Society"},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib11","first-page":"1789","article-title":"The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas","volume":"85","author":"Arafah","year":"2000","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"7","key":"10.1016\/j.yexcr.2024.114279_bib12","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1210\/jc.2018-00688","article-title":"Clinical and pathological aspects of silent pituitary adenomas","volume":"104","author":"Drummond","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib13","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114279_bib14","first-page":"241","article-title":"Diagnosis and treatment of pituitary adenomas","volume":"29","author":"Chanson","year":"2004","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.yexcr.2024.114279_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fendo.2019.00290","article-title":"The epigenomics of pituitary adenoma","volume":"10","author":"Hauser","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2024.114279_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154529","article-title":"The interplay of signaling pathways and miRNAs in the pathogenesis and targeted therapy of esophageal cancer","volume":"246","author":"Doghish","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154947","article-title":"Deciphering signaling pathway interplay via miRNAs in malignant pleural mesothelioma","author":"Salman","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib18","series-title":"MicroRNA: Exploring Their Multifaceted Role in Cancer","author":"Hamdy","year":"2024"},{"issue":"D1","key":"10.1016\/j.yexcr.2024.114279_bib19","doi-asserted-by":"crossref","first-page":"D354","DOI":"10.1093\/nar\/gkx854","article-title":"miRandola 2017: a curated knowledge base of non-invasive biomarkers","volume":"46","author":"Russo","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yexcr.2024.114279_bib20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF03346759","article-title":"MicroRNAs: suggested role in pituitary adenoma pathogenesis","volume":"36","author":"Gadelha","year":"2013","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.yexcr.2024.114279_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154510","article-title":"The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance\u2013A focus on signaling pathways interplay","volume":"246","author":"Hegazy","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154439","article-title":"miRNAs as potential game-changers in renal cell carcinoma: future clinical and medicinal uses","volume":"245","author":"Elballal","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0043-123763","article-title":"MicroRNAs and target genes in pituitary adenomas","volume":"50","author":"Feng","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.20832","article-title":"Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas","volume":"210","author":"Bottoni","year":"2007","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.yexcr.2024.114279_bib25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1507\/endocrj.EJ18-0487","article-title":"Next-generation sequencing of microRNAs reveals a unique expression pattern in different types of pituitary adenomas","volume":"66","author":"He","year":"2019","journal-title":"Endocr. J."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1227\/NEU.0000000000000369","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Di Ieva","year":"2014","journal-title":"Neurosurgery"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12864-023-09478-z","article-title":"Integrated analysis of lncRNA\/circRNA\u2013miRNA\u2013mRNA in the proliferative phase of liver regeneration in mice with liver fibrosis","volume":"24","author":"Wang","year":"2023","journal-title":"BMC Genom."},{"key":"10.1016\/j.yexcr.2024.114279_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.753931","article-title":"Interactions among lncRNA\/circRNA, miRNA, and mRNA in musculoskeletal degenerative diseases","volume":"9","author":"Zheng","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.yexcr.2024.114279_bib29","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.7150\/jca.91546","article-title":"Identification of a lncRNA\/circRNA-miRNA-mRNA network in Nasopharyngeal Carcinoma by deep sequencing and bioinformatics analysis","volume":"15","author":"Liu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.yexcr.2024.114279_bib30","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.yexcr.2024.114279_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154183","article-title":"Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association","volume":"240","author":"El-Sheikh","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.ijbiomac.2022.09.209","article-title":"Interactome battling of lncRNA CCDC144NL-AS1: its role in the emergence and ferocity of cancer and beyond","volume":"222","author":"Abd El Fattah","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.yexcr.2024.114279_bib33","article-title":"Defining disease-related modules based on weighted miRNA synergistic network","volume":"152","author":"Li","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ncrna.2023.03.004","article-title":"Telomerase RNA component lncRNA as potential diagnostic biomarker promotes CRC cellular migration and apoptosis evasion via modulation of \u03b2-catenin protein level","volume":"8","author":"Bakr","year":"2023","journal-title":"Non-coding RNA Research"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib35","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/jcp.21993","article-title":"Genomic organization of microRNAs","volume":"222","author":"Olena","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"10a","key":"10.1016\/j.yexcr.2024.114279_bib36","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","article-title":"Identification of mammalian microRNA host genes and transcription units","volume":"14","author":"Rodriguez","year":"2004","journal-title":"Genome Res."},{"issue":"7014","key":"10.1016\/j.yexcr.2024.114279_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2024.114279_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mito.2022.08.002","article-title":"Mitochondrial miRNAs (MitomiRs): their potential roles in breast and other cancers","volume":"66","author":"Erturk","year":"2022","journal-title":"Mitochondrion"},{"issue":"10","key":"10.1016\/j.yexcr.2024.114279_bib39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41477-021-01000-1","article-title":"Structural basis of microRNA processing by Dicer-like 1","volume":"7","author":"Wei","year":"2021","journal-title":"Nat. Plants"},{"issue":"11","key":"10.1016\/j.yexcr.2024.114279_bib40","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1101\/gad.1919710","article-title":"Emerging paradigms of regulated microRNA processing","volume":"24","author":"Newman","year":"2010","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib41","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2024.114279_bib42","doi-asserted-by":"crossref","unstructured":"K. Ergin, R. \u00c7etinkaya, Regulation of microRNAs, miRNomics, Springer2022, pp. 1-32.","DOI":"10.1007\/978-1-0716-1170-8_1"},{"issue":"7149","key":"10.1016\/j.yexcr.2024.114279_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.yexcr.2024.114279_bib44","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1101\/gad.1705308","article-title":"Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs","volume":"22","author":"Babiarz","year":"2008","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib45","first-page":"276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020"},{"issue":"7","key":"10.1016\/j.yexcr.2024.114279_bib46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1134\/S0006297921070014","article-title":"MicroRNAs in cancer: from gene expression regulation to the metastatic niche reprogramming","volume":"86","author":"Semina","year":"2021","journal-title":"Biochemistry (Moscow)"},{"issue":"19","key":"10.1016\/j.yexcr.2024.114279_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197287","article-title":"MiRNAs as noninvasive biomarkers and therapeutic agents of pituitary adenomas","volume":"21","author":"Beylerli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8060148","article-title":"Biomarkers for liquid biopsies of pituitary neuroendocrine tumors","volume":"8","author":"Gossing","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2024.114279_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154509","article-title":"Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: a review","volume":"246","author":"Abdelmaksoud","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mgene.2018.11.006","article-title":"Diagnostic significance of miR-639 and miR-10b in \u0392reast cancer patients","volume":"19","author":"Ismail","year":"2019","journal-title":"Meta Gene"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1055\/s-0043-123763","article-title":"MicroRNAs and target genes in pituitary adenomas","volume":"50","author":"Feng","year":"2018","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","article-title":"microRNAs as oncogenes and tumor suppressors","volume":"302","author":"Zhang","year":"2007","journal-title":"Dev. Biol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib53","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000521388","article-title":"The involvement of miRNAs in pituitary adenomas pathogenesis and the clinical implications","volume":"85","author":"Xu","year":"2022","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.yexcr.2024.114279_bib54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2024.114279_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","author":"Al-Noshokaty","year":"2022","journal-title":"J. Life Sci."},{"key":"10.1016\/j.yexcr.2024.114279_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120325","article-title":"Exosomal-long non-coding RNAs journey in colorectal cancer: evil and goodness faces of key players","volume":"292","author":"Rizk","year":"2022","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib57","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s40618-022-01964-7","article-title":"MicroRNA-137 inhibits pituitary prolactinoma proliferation by targeting AKT2","volume":"46","author":"Xu","year":"2023","journal-title":"J. Endocrinol. Invest."},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000517356","article-title":"MicroRNAs in dopamine agonist-resistant prolactinoma","volume":"112","author":"Wan","year":"2022","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000497746","article-title":"Epidemiology and management challenges in prolactinomas","volume":"109","author":"Vroonen","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.yexcr.2024.114279_bib60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2017.01.021","article-title":"MicroRNAs in pituitary tumors","volume":"456","author":"Wierinckx","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yexcr.2024.114279_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2018.09.019","article-title":"Emerging microRNAs in cancer diagnosis, progression, and immune surveillance","volume":"438","author":"Harrandah","year":"2018","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13148-018-0587-8","article-title":"The role and mechanisms of action of microRNAs in cancer drug resistance","volume":"11","author":"Si","year":"2019","journal-title":"Clin. Epigenet."},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib63","first-page":"320","article-title":"Differential expression analysis of prolactinoma-related microRNAs","volume":"92","author":"Chen","year":"2012","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib64","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa220","article-title":"MicroRNA-7a2 regulates prolactin in developing lactotrophs and prolactinoma cells","volume":"162","author":"LaPierre","year":"2021","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib65","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1210\/jc.2018-02544","article-title":"MiR-137's tumor suppression on prolactinomas by targeting MITF and modulating Wnt signaling pathway","volume":"104","author":"Lei","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib66","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1515\/chem-2019-0036","article-title":"miRNA-199a-5p functions as a tumor suppressor in prolactinomas","volume":"17","author":"Jichao","year":"2019","journal-title":"Open Chem."},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib67","first-page":"1312","article-title":"microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment","volume":"27","author":"Wang","year":"2012","journal-title":"Oncol. Rep."},{"issue":"1\u20132","key":"10.1016\/j.yexcr.2024.114279_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2014.07.014","article-title":"MicroRNA expression profile of bromocriptine-resistant prolactinomas","volume":"395","author":"Wu","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.yexcr.2024.114279_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.brainresbull.2019.03.013","article-title":"miR-93-5p targets Smad7 to regulate the transforming growth factor-\u03b21\/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma","volume":"149","author":"Hu","year":"2019","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JOE-18-0203","article-title":"MicroRNA-93 mediates cabergoline resistance by targeting ATG7 in prolactinoma","volume":"240","author":"Wu","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yexcr.2024.114279_bib71","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40618-018-0963-4","article-title":"Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1","volume":"42","author":"Jian","year":"2019","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib72","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2019.09.070","article-title":"MiR-1299 promotes the synthesis and secretion of prolactin by inhibiting FOXO1 expression in drug-resistant prolactinomas","volume":"520","author":"Xiao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114279_bib73","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/2010.7.FOCUS10169","article-title":"Growth hormone-secreting adenomas: pathology and cell biology","volume":"29","author":"Lopes","year":"2010","journal-title":"Neurosurg. Focus"},{"issue":"10","key":"10.1016\/j.yexcr.2024.114279_bib74","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/BF03346759","article-title":"MicroRNAs: suggested role in pituitary adenoma pathogenesis","volume":"36","author":"Gadelha","year":"2013","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.yexcr.2024.114279_bib75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1746-1596-5-79","article-title":"Differential expression of microRNAs in GH-secreting pituitary adenomas","volume":"5","author":"Mao","year":"2010","journal-title":"Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114279_bib76","doi-asserted-by":"crossref","first-page":"R331","DOI":"10.1530\/ERC-14-0188","article-title":"The PI3K\/AKT\/mTOR pathway in the pathophysiology and treatment of pituitary adenomas","volume":"21","author":"Monsalves","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib77","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1677\/ERC-08-0012","article-title":"Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update","volume":"15","author":"Salehi","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.yexcr.2024.114279_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8516858","article-title":"Identification of serum miRNA-423-5p expression signature in somatotroph adenomas","volume":"2019","author":"Zhao","year":"2019","journal-title":"International journal of endocrinology"},{"issue":"7","key":"10.1016\/j.yexcr.2024.114279_bib79","doi-asserted-by":"crossref","first-page":"E1128","DOI":"10.1210\/jc.2011-3482","article-title":"Altered MicroRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1","volume":"97","author":"D'Angelo","year":"2012","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib80","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/modpathol.2008.202","article-title":"Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas","volume":"22","author":"Qian","year":"2009","journal-title":"Mod. Pathol. : an official journal of the United States and Canadian Academy of Pathology, Inc"},{"issue":"13","key":"10.1016\/j.yexcr.2024.114279_bib81","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/onc.2012.190","article-title":"Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN\u2013AKT pathway","volume":"32","author":"Palumbo","year":"2013","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib82","first-page":"5833","article-title":"The biochemical and clinical implications of phosphatase and tensin homolog deleted on chromosome ten in different cancers","volume":"11","author":"Wang","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2024.114279_bib83","article-title":"Roles of BMI1 in the initiation, progression, and treatment of hepatocellular carcinoma","volume":"21","author":"Wang","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.yexcr.2024.114279_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00904","article-title":"Interplay of EMT and CSC in cancer and the potential therapeutic strategies","volume":"11","author":"Tanabe","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib85","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.23736\/S0031-0808.17.03386-9","article-title":"Tumor suppressor role of miR-503","volume":"60","author":"Gupta","year":"2018","journal-title":"Panminerva Med."},{"key":"10.1016\/j.yexcr.2024.114279_bib87","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.2147\/OTT.S257951","article-title":"miR-525-5p modulates proliferation and epithelial-mesenchymal transition of glioma by targeting stat-1","volume":"13","author":"Xie","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"8","key":"10.1016\/j.yexcr.2024.114279_bib88","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1007\/s10620-019-05916-9","article-title":"MiR-525-5p repressed metastasis and anoikis resistance in cervical cancer via blocking UBE2C\/ZEB1\/2 signal Axis","volume":"65","author":"Chen","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib89","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jcp.20282","article-title":"miR-15a and miR-16-1 down-regulation in pituitary adenomas","volume":"204","author":"Bottoni","year":"2005","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/s-0028-1096125","article-title":"MicroRNAs and possible role in pituitary adenoma","volume":"26","author":"Zatelli","year":"2008","journal-title":"Semin. Reprod. Med."},{"issue":"11","key":"10.1016\/j.yexcr.2024.114279_bib91","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/carcin\/bgs261","article-title":"The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma","volume":"33","author":"Chen","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401377","article-title":"The role of Notch and Hedgehog signaling pathways in pituitary development and pathogenesis of pituitary adenomas","volume":"14","author":"Yavropoulou","year":"2015","journal-title":"Hormones (Basel)"},{"issue":"10","key":"10.1016\/j.yexcr.2024.114279_bib93","first-page":"789","article-title":"MiR-524-5p suppresses migration, invasion, and EMT progression in breast cancer cells through targeting FSTL1","volume":"35","author":"Jin","year":"2020","journal-title":"Cancer Biother. Rad."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114279_bib94","doi-asserted-by":"crossref","first-page":"G827","DOI":"10.1152\/ajpgi.00369.2019","article-title":"miR-524-5p inhibits angiogenesis through targeting WNK1 in colon cancer cells","volume":"318","author":"Li","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.yexcr.2024.114279_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111198","article-title":"An update on the role of miR-124 in the pathogenesis of human disorders","volume":"135","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib96","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12020-017-1390-6","article-title":"Increased miR-338-3p expression correlates with invasiveness of GH-producing pituitary adenomas","volume":"58","author":"Lee","year":"2017","journal-title":"Endocrine"},{"issue":"9","key":"10.1016\/j.yexcr.2024.114279_bib97","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1007\/s13277-014-2143-2","article-title":"Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib98","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13277-014-2609-2","article-title":"Pttg1 inhibits TGF\u03b2 signaling in breast cancer cells to promote their growth","volume":"36","author":"Zhang","year":"2015","journal-title":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine"},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib99","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1210\/jcem.84.2.5432","article-title":"Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas","volume":"84","author":"Zhang","year":"1999","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib100","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/JOE-17-0254","article-title":"AIP and the somatostatin system in pituitary tumours","volume":"235","author":"Ib\u00e1\u00f1ez-Costa","year":"2017","journal-title":"J. Endocrinol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib101","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1152\/ajpendo.00546.2011","article-title":"MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro","volume":"303","author":"Trivellin","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metabol."},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib102","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1002\/ijc.33268","article-title":"miR-34a is upregulated in AIP-mutated somatotropinomas and promotes octreotide resistance","volume":"147","author":"Bogner","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032875","article-title":"miR-383-5p, miR-181a-5p, and miR-181b-5p as predictors of response to first-generation somatostatin receptor ligands in acromegaly","volume":"24","author":"Henriques","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.yexcr.2024.114279_bib104","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.3906\/sag-2010-245","article-title":"Circulating miR-29c-3p is downregulated in patients with acromegaly","volume":"51","author":"Korkmaz","year":"2021","journal-title":"Turk. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/clinem\/dgab695","article-title":"Circulating plasma MicroRNA in patients with active acromegaly","volume":"107","author":"Lutsenko","year":"2022","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib106","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.3892\/ol.2020.11845","article-title":"miR-452-5p and miR-215-5p expression levels in colorectal cancer tissues and their relationship with clinicopathological features","volume":"20","author":"Yan","year":"2020","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib107","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.yexcr.2024.114279_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.924952","article-title":"Acromegaly and colorectal neoplasm: an update","volume":"13","author":"Kasuki","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib109","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.3390\/ijms23126469","article-title":"The role of glucocorticoid receptor in the pathophysiology of pituitary corticotroph adenomas","volume":"23","author":"Regazzo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2008-1451","article-title":"MicroRNAs differentially expressed in ACTH-secreting pituitary tumors","volume":"94","author":"Amaral","year":"2009","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.yexcr.2024.114279_bib111","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12020-010-9346-0","article-title":"MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and-493 in pituitary carcinomas","volume":"38","author":"Stilling","year":"2010","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.yexcr.2024.114279_bib112","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/en.2012-2070","article-title":"miR-26a plays an important role in cell cycle regulation in ACTH-secreting pituitary adenomas by modulating protein kinase C\u03b4","volume":"154","author":"Gentilin","year":"2013","journal-title":"Endocrinology"},{"issue":"21","key":"10.1016\/j.yexcr.2024.114279_bib113","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1074\/jbc.270.21.12665","article-title":"Components of a new human protein kinase signal transduction pathway","volume":"270","author":"Zhou","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.yexcr.2024.114279_bib114","doi-asserted-by":"crossref","first-page":"10361","DOI":"10.1074\/jbc.M112.425504","article-title":"MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.yexcr.2024.114279_bib116","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13169","article-title":"Aggressive corticotroph tumors and carcinomas","volume":"34","author":"Lasolle","year":"2022","journal-title":"J. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib117","first-page":"310","article-title":"miRNA-93-5p promotes gemcitabine resistance in pancreatic cancer cells by targeting the PTEN-mediated PI3K\/Akt signaling pathway","volume":"51","author":"Wu","year":"2021","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib118","first-page":"346","article-title":"Mechanism of miRNA-31 regulating wnt\/\u03b2-catenin signaling pathway by targeting Satb2 in the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells","volume":"23","author":"Ouyang","year":"2023","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib119","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1210\/jc.2010-1885","article-title":"Wnt\/\u03b2-catenin pathway activation in adrenocortical adenomas is frequently due to somatic CTNNB1-activating mutations, which are associated with larger and nonsecreting tumors: a study in cortisol-secreting and-nonsecreting tumors","volume":"96","author":"Bonnet","year":"2011","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"14","key":"10.1016\/j.yexcr.2024.114279_bib120","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.3390\/ijms23147676","article-title":"Characterization of adrenal miRNA-based dysregulations in Cushing's syndrome","volume":"23","author":"Vetrivel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2024.114279_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.620012","article-title":"Circulating microRNA expression in cushing's syndrome","volume":"12","author":"Vetrivel","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib122","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1111\/jcmm.14297","article-title":"TSP\u20101 is downregulated and inversely correlates with miR\u2010449c expression in Cushing's disease","volume":"23","author":"Ren","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/ncrna7030055","article-title":"Micrornas as potential biomarkers in pituitary adenomas","volume":"7","author":"Donati","year":"2021","journal-title":"Non-coding RNA"},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-14-352","article-title":"Identification of miRNAs associated with sexual maturity in chicken ovary by Illumina small RNA deep sequencing","volume":"14","author":"Kang","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.yexcr.2024.114279_bib125","first-page":"1","volume":"1","author":"Juanchich","year":"2013","journal-title":"Identification of differentially expressed miRNAs and their potential targets during fish oogenesis"},{"issue":"12","key":"10.1016\/j.yexcr.2024.114279_bib126","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1261\/rna.754207","article-title":"Cloning and expression profiling of small RNAs expressed in the mouse ovary","volume":"13","author":"Ro","year":"2007","journal-title":"RNA"},{"key":"10.1016\/j.yexcr.2024.114279_bib127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7827-9-2","article-title":"Expression of miRNAs in ovine fetal gonads: potential role in gonadal differentiation","volume":"9","author":"Torley","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.111.093252","article-title":"Cell-secreted vesicles in equine ovarian follicular fluid contain miRNAs and proteins: a possible new form of cell communication within the ovarian follicle","volume":"86","author":"da Silveira","year":"2012","journal-title":"Biol. Reprod."},{"issue":"1\u20134","key":"10.1016\/j.yexcr.2024.114279_bib129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.anireprosci.2010.03.001","article-title":"Cloning and analysis of fetal ovary microRNAs in cattle","volume":"120","author":"Tripurani","year":"2010","journal-title":"Anim. Reprod. Sci."},{"issue":"7","key":"10.1016\/j.yexcr.2024.114279_bib130","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.7150\/ijbs.7.1045","article-title":"Repertoire of porcine microRNAs in adult ovary and testis by deep sequencing","volume":"7","author":"Li","year":"2011","journal-title":"Int. J. Biol. Sci."},{"issue":"5858","key":"10.1016\/j.yexcr.2024.114279_bib131","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.yexcr.2024.114279_bib132","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib133","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/ng1969","article-title":"DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal","volume":"39","author":"Wang","year":"2007","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib134","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1095\/biolreprod.110.088476","article-title":"Manipulation of estrogen synthesis alters MIR202\u2217 expression in embryonic chicken gonads","volume":"85","author":"Bannister","year":"2011","journal-title":"Biol. Reprod."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/en.2002-220477","article-title":"Follicle-stimulating hormone-responsive cytoskeletal genes in rat granulosa cells: class I \u03b2-tubulin, tropomyosin-4, and kinesin heavy chain","volume":"144","author":"Grieshaber","year":"2003","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.yexcr.2024.114279_bib136","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1210\/en.2011-1147","article-title":"Micro-RNA378 (miR-378) regulates ovarian estradiol production by targeting aromatase","volume":"152","author":"Xu","year":"2011","journal-title":"Endocrinology"},{"issue":"18","key":"10.1016\/j.yexcr.2024.114279_bib137","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib138","doi-asserted-by":"crossref","first-page":"e2597","DOI":"10.1038\/cddis.2017.24","article-title":"MicroRNA-144 is regulated by CP2 and decreases COX-2 expression and PGE2 production in mouse ovarian granulosa cells","volume":"8","author":"Zhou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2024.114279_bib139","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11626-015-9977-9","article-title":"MicroRNA-764-3p regulates 17\u03b2-estradiol synthesis of mouse ovarian granulosa cells by targeting steroidogenic factor-1","volume":"52","author":"Wang","year":"2016","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"26","key":"10.1016\/j.yexcr.2024.114279_bib140","doi-asserted-by":"crossref","first-page":"18239","DOI":"10.1074\/jbc.M113.546044","article-title":"Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins","volume":"289","author":"Yin","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.yexcr.2024.114279_bib141","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.febslet.2013.06.023","article-title":"MicroRNA-133b stimulates ovarian estradiol synthesis by targeting Foxl2","volume":"587","author":"Dai","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2024.114279_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154690","article-title":"The potential role of miRNAs in the pathogenesis of adrenocortical carcinoma-A focus on signaling pathways interplay","author":"Midan","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154817","article-title":"Melodic maestros: unraveling the role of miRNAs in the diagnosis, progression, and drug resistance of malignant pleural mesothelioma","volume":"250","author":"Abd-Elmawla","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154771","article-title":"The emerging role of miRNAs in Merkel cell carcinoma pathogenesis: signaling pathway crosstalk","author":"Rizk","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2024.114279_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154684","article-title":"miRNAs orchestration of gallbladder cancer-Particular emphasis on diagnosis, progression and drug resistance","author":"Shahin","year":"2023","journal-title":"Pathol. Res. Pract."},{"issue":"16","key":"10.1016\/j.yexcr.2024.114279_bib146","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.7150\/thno.32543","article-title":"The miR-561-5p\/CX3CL1 signaling axis regulates pulmonary metastasis in hepatocellular carcinoma involving CX3CR1+ natural killer cells infiltration","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib147","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2019.02.029","article-title":"Reassessment of exosome composition","volume":"177","author":"Jeppesen","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.yexcr.2024.114279_bib148","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccell.2016.10.009","article-title":"Extracellular vesicles in cancer: cell-to-cell mediators of metastasis","volume":"30","author":"Becker","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.yexcr.2024.114279_bib149","first-page":"2491","article-title":"miR-16 regulates proliferation and apoptosis of pituitary adenoma cells by inhibiting HMGA2","volume":"17","author":"Niu","year":"2019","journal-title":"Oncol. Lett."},{"issue":"7593","key":"10.1016\/j.yexcr.2024.114279_bib150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2024.114279_bib151","first-page":"1","article-title":"Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas","author":"Zhao","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.yexcr.2024.114279_bib152","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating microRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.yexcr.2024.114279_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.771354","article-title":"Exosomal miRNA profiling is a potential screening route for non-functional pituitary adenoma","volume":"9","author":"Lyu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.yexcr.2024.114279_bib154","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1210\/jc.2018-02479","article-title":"Comprehensive analysis of circulating miRNAs in the plasma of patients with pituitary adenomas","volume":"104","author":"N\u00e9meth","year":"2019","journal-title":"J. Clin. Endocrinol. Metabol."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib155","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12957-021-02383-3","article-title":"Potential biomarkers of miRNA in non-functional pituitary adenomas","volume":"19","author":"Zhang","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"18","key":"10.1016\/j.yexcr.2024.114279_bib156","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.3390\/cells11182920","article-title":"Emerging roles of miRNA, lncRNA, circRNA, and their cross-talk in pituitary adenoma","volume":"11","author":"Wu","year":"2022","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.yexcr.2024.114279_bib157","first-page":"1235","article-title":"MicroRNA-16\/VEGFR2\/p38\/NF-\u03baB signaling pathway regulates cell growth of human pituitary neoplasms","volume":"39","author":"Lu","year":"2018","journal-title":"Oncol. Rep."},{"issue":"14","key":"10.1016\/j.yexcr.2024.114279_bib158","article-title":"Expression and clinical significance of miR-193a-3p in invasive pituitary adenomas","volume":"24","author":"Su","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2024.114279_bib159","article-title":"Identification of serum miRNA\u2010423\u20105p expression signature in somatotroph adenomas","author":"Zhao","year":"2019","journal-title":"International journal of endocrinology"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724003707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482724003707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:18:58Z","timestamp":1736176738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482724003707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":159,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0014482724003707"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114279","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging role of miRNAs in pituitary adenomas: From molecular signatures to diagnostic potential","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2024.114279","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114279"}}